Based on the indicators this is still not a buy - for me at least. I am looking forward to enter though if I see an evidence in the signals.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025